Notably, HER2-enriched tumours exhibited the highest expression of these proteins, highlighting that HER2+ breast tumours demonstrate higher metabolic plasticity with elevated lipid metabolism compared to other subtypes [247]. Here, ERBB2 is linked to breast neoplasm.